Sumitomo Pharma Co., Ltd. (TYO:4506)

Market Cap	308.69B
Revenue (ttm)	372.71B
Net Income (ttm)	-176.04B
Shares Out	397.29M
EPS (ttm)	-443.11
PE Ratio	n/a
Forward PE	26.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,648,300
Average Volume	3,940,725
Open	765.00
Previous Close	767.00
Day's Range	758.00 - 777.00
52-Week Range	279.00 - 838.00
Beta	0.61
RSI	66.84
Earnings Date	Jan 31, 2025

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson’s disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It provides products for atypical anti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 4,980
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4506

Financial Performance

In 2023, Sumitomo Pharma's revenue was 314.56 billion, a decrease of -43.38% compared to the previous year's 555.54 billion. Losses were -314.97 billion, 322.7% more than in 2022.